U.S. markets closed

1Life Healthcare, Inc. (ONEM)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
42.18+0.08 (+0.19%)
At close: 4:00PM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bullishpattern detected
Price Crosses Moving Average

Price Crosses Moving Average

Previous Close42.10
Open41.61
Bid42.26 x 1100
Ask42.99 x 1300
Day's Range40.87 - 42.31
52 Week Range17.66 - 59.82
Volume453,833
Avg. Volume1,415,075
Market Cap5.485B
Beta (5Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)-2.76
Earnings DateFeb 25, 2021
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est54.67
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
View more
  • Teladoc, 1Life stocks are still bullish after Amazon Care's rollout leads to selloff, analyst says
    MarketWatch

    Teladoc, 1Life stocks are still bullish after Amazon Care's rollout leads to selloff, analyst says

    Shares of Teladoc Health Inc. and One Medical-parent 1Life Healthcare Inc. extended losses Thursday, in the wake of Amazon.com Inc. announcement on Wednesday that it will be rolling out its Amazon Care telemedicine program nationwide. Teledoc's stock slumped 2.3% in afternoon trading, after shedding 4.4% on Wednesday, while 1Life shares slid 4.1% after losing 0.8% the day before. "Clearly, competition has increased, and we do not discount Amazon's potential for success," Canaccord Genuity analyst Richard Close wrote in a note to clients. Of the companies he covers, Close said competition will be greatest for Teladoc and One Medical, but noted that it doesn't mean investors should give up on the companies. "In the past, rumblings of Amazon's healthcare services interests have been buying opportunities," Close wrote. He recommended his buy ratings on Teladoc and 1Life, saying he does not believe the Amazon Care news has materially damaged the near-term opportunity for solid growth. "There should be ample opportunities for sustained growth going forward," he wrote. Teladoc's stock has lost 5.4% over the past three months and 1Life shares have ticked up 0.4%. In comparison, Amazon's stock has slipped 3.8% over the same time, while the SPDR Health Care Select Sector ETF has edged up 2.2% and the S&P 500 has gained 6.7%.

  • One Medical Under Investigation By House Subcommittee, Allegedly Let Subscribers Cut COVID-19 Vaccine Line
    Benzinga

    One Medical Under Investigation By House Subcommittee, Allegedly Let Subscribers Cut COVID-19 Vaccine Line

    One Medical, a subscription-based concierge health care provider, is now under investigation by a Congressional committee, accused of administering COVID-19 vaccines to family, friends, executives and wealthy clients, according to CNBC. What Happened: One Medical is owned by 1life Healthcare Inc. (NASDAQ: ONEM). As the supply of COVID-19 vaccines remains scarce, the elderly, those at high risk and frontline workers are top priority for receiving the vaccine. In a letter written by the Rep. James Clyburn, chairman of the House Select Subcommittee on the Coronavirus Crisis, One Medical is asked to provide documentation on its vaccine allocation process. “One Medical reportedly prioritized appointments for friends and family of the company’s leadership, an executive at a partner organization, and work-from-home staff at the company’s headquarters—none of whom were eligible under state and local guidelines,” the South Carolina Democrat wrote. “Prior to January 14, 2021, the company failed to require patients to answer a question about eligibility when registering for vaccination appointments. Since then, the company reportedly has not enforced requirements to provide proof of eligibility and has even allowed some patients who stated they were not in an eligible category to still book vaccination appointments.” One Medical Responds: To subscribe to One Medical, users pay $199 annually to be on the platform and receive VIP health care treatment in their area, with access to automated appointment scheduling and booking. "We remain committed to serving our communities and hope that this report does not impede our ability to continue doing this vital work," One Medical said in a statement on Twitter. ONEM Price Action: 1life Healthcare shares were down 5.72% at $46.01 at last check Tuesday. See more from BenzingaClick here for options trades from BenzingaNBA Top Shot, CryptoPunks And More: What You Need To Know About NFTsKevin O'Leary Starts Day Trading, Says Reddit Users 'Aren't Stupid'© 2021 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

  • MarketWatch

    Global COVID cases top 113 million as FDA committee meets to vote on J&J vaccine

    The number of confirmed cases of the coronavirus-borne illness COVID-19 climbed above 113 million on Friday, amid a flurry of positive vaccine news and as a regulatory advisory committee gathered to review Johnson & Johnson's vaccine candidate for a possible emergency use authorization.